We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REG icon
451
PUT
Regency Centers
REG
$14.1B
$1.35M 0.04%
25,000
EDU icon
452
New Oriental
EDU
$8.98B
$1.35M 0.04%
16,466
+8,225
+100% +$998K
BKNG icon
453
Booking.com
BKNG
$161B
$1.35M 0.04%
15,400
-23,150
-60% -$2.16M
DIDI
454
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$1.34M 0.04%
+95,095
New +$1.34M
CBOE icon
455
Cboe Global Markets
CBOE
$29.9B
$1.34M 0.04%
11,284
-5,459
-33% -$599K
GPOR icon
456
Gulfport Energy Corp
GPOR
$2.88B
$1.33M 0.04%
+20,606
New +$1.32M
XBI icon
457
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.33M 0.04%
+9,797
New +$1.29M
CIVI
458
DELISTED
Civitas Resources
CIVI
$1.33M 0.04%
28,168
-45,696
-62% -$1.85M
LRCX icon
459
PUT
Lam Research
LRCX
$390B
$1.31M 0.04%
24,000
-96,000
-80% -$6.06M
OXY icon
460
Occidental Petroleum
OXY
$55.9B
$1.31M 0.04%
41,985
+11,523
+38% +$309K
CYRX icon
461
CryoPort
CYRX
$762M
$1.31M 0.04%
20,705
-1,233
-6% -$69.4K
EQX icon
462
Equinox Gold
EQX
$13.5B
$1.31M 0.04%
187,900
+27,805
+17% +$238K
SM icon
463
SM Energy
SM
$6.87B
$1.31M 0.04%
+53,018
New +$1.03M
AWH
464
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.3M 0.04%
15,471
DOX icon
465
Amdocs
DOX
$6.22B
$1.3M 0.04%
16,791
+2,409
+17% +$186K
NFLX icon
466
CALL
Netflix
NFLX
$309B
$1.3M 0.04%
29,000
+18,000
+164% +$920K
FMNB icon
467
Farmers National Banc Corp
FMNB
$930M
$1.29M 0.04%
83,422
+37,592
+82% +$631K
ERIC icon
468
Ericsson
ERIC
$33.3B
$1.29M 0.04%
102,699
-48,844
-32% -$654K
SYNH
469
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.29M 0.04%
14,415
-4,187
-23% -$354K
OPAD icon
470
Offerpad Solutions
OPAD
$23.1M
$1.29M 0.04%
865
VST icon
471
CALL
Vistra
VST
$47.4B
$1.29M 0.04%
69,500
-98,000
-59% -$1.69M
PNTM
472
DELISTED
Pontem Corporation
PNTM
$1.28M 0.04%
132,003
+116,484
+751% +$1.13M
CAE icon
473
CAE Inc. Common Shares
CAE
$8.74B
$1.28M 0.04%
41,572
+22,199
+115% +$679K
BABA icon
474
PUT
Alibaba
BABA
$308B
$1.28M 0.04%
5,800
-8,600
-60% -$1.91M
FMIVU
475
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$1.28M 0.04%
127,750
-50,000
-28% -$500K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.